Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesotheliomaVanesa Gregorc, Paolo A Zucali, Armando Santoro, et al.Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective studyElisa Gobbini, Domenico Galetta, Marcello Tiseo, et al.Journal of the National Cancer Institute|June 7, 2007
Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional studyFumiko Taguchi, Benjamin Solomon, Vanesa Gregorc, et al.Journal for Immunotherapy of Cancer|August 23, 2023
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLCPaola Trono, Annalisa Tocci, Belinda Palermo, et al.The Lancet. Oncology|May 17, 2014
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trialVanesa Gregorc, Silvia Novello, Chiara Lazzari, et al.Lancet (London, England)|August 9, 2025
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trialFabrice Barlesi, Wenxiu Yao, Michaël Duruisseaux, et al.Lung Cancer (Amsterdam, Netherlands)|January 3, 2025
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experienceFrancesca Rita Ogliari, Alberto Traverso, Simone Barbieri, et al.Clinical Lung Cancer|March 1, 2021
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung CancerVanesa Gregorc, Luca Mazzarella, Chiara Lazzari, et al.STAR Protocols|February 13, 2025
Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cellsJiajia Tang, Quan Zheng, Qi Wang, et al.Cell Reports. Medicine|August 20, 2024
CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approachesJiajia Tang, Quan Zheng, Qi Wang, et al.Pageof 10